Abd El-wahab, H. A. A., Aboraia, A. S., Abdel-Rahman, H. M., El-Gendy, M. A. and Simons, Claire ![]() ![]() |
Preview |
PDF
- Published Version
Download (303kB) | Preview |
Official URL: https://www.derpharmachemica.com/abstract/mycobact...
Abstract
Despite the introduction of the first line treatment regimen forty years ago and the continuous trials since that time to introduce new regimens, tuberculosis (TB) is considered to be the cause of considerable mortality worldwide. Recent research highlighted the Mycobacterium tuberculosis (Mtb)CYP450s as potential drug targets. This article reviews mycobacterial CYP121 as a target for anti-TB drug discovery.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Pharmacy |
Subjects: | R Medicine > RM Therapeutics. Pharmacology |
ISSN: | 0975-413X |
Date of First Compliant Deposit: | 25 June 2016 |
Date of Acceptance: | 26 April 2016 |
Last Modified: | 05 May 2023 23:32 |
URI: | https://orca.cardiff.ac.uk/id/eprint/92134 |
Citation Data
Cited 1 time in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
![]() |
Edit Item |